ACTRN12605000304639
Completed
N/A
Can a novel measure of acute bronchodilator responsiveness predict improvement in exercise capacity after four weeks treatment with tiotropium bromide in subjects with chronic obstructive pulmonary disease?
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chronic obstructive pulmonary disease
- Sponsor
- Woolcock Institute of Medical Research
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Moderate to severe chronic obstructive pulmonary disease, with FEV1 \< 60% predicted and FEV1/FVC\<70%
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The effect of prophylactic bronchodilator treatment with transdermal tulobuterol patch on lung compliance and airway resistanceDiseases of th respiratory systemKCT0001152Pusan National University Hospital82
Completed
N/A
Efficacy of long-acting bronchodilators on dynamic lung hyperinflation in chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease (COPD)JPRN-UMIN000027446Shinshu University School of Health Sciences30
Not Yet Recruiting
N/A
Comparision of low dose (200 mcg) versus high dose (400mcg) bronchodilator response in asthmatic childreHealth Condition 1: J459- Other and unspecified asthmaCTRI/2024/04/065106Department of Pediatrics
Recruiting
Phase 4
Evaluation of the Use of Guaco Syrup for Dilation and Reduction of Inflammation in the Respiratory Tract Through Pulmonary Function Tests in Asthmatic VolunteersAsthmaC08.127.108RBR-4n26tfniversidade federal do paraná
Active, Not Recruiting
N/A
Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthmaAsthmaMedDRA version: 16.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2013-002517-35-DEPierre Fabre Médicament/Institut de Recherche Pierre Fabre